| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |